Rodney D. Altman, MD has been a healthcare investor since 2000. From 2006-2011, he was at CMEA Capital where he invested in SurgiQuest, Visiogen (acquired by Abbott in 2009), InSound Medical (acquired by Sonova in 2010), and VasoNova (acquired by Teleflex in 2011). Rod was Chairman of the Board of VasoNova.
Prior to becoming a healthcare investor, Rod practiced emergency medicine for 10 years. Today, he continues to work in emergency medicine part time at Stanford University Medical Center, where he is a Clinical Assistant Professor of Emergency Medicine in the Department of Surgery.
Dr. Altman was a Co-Founder and Managing Director of Aphelion Capital. He also worked at Piper Jaffray Ventures and was a Partner at TVM Techno Venture Management. At those firms, Rod’s investments included Confluent Surgical (invested from TVM and acquired by Tyco Surgical in 2006) and Insulet (now public, invested from Piper Jaffray/Sightline Partners and from Aphelion). Dr. Altman received his MD from McGill University and an MBA from the University of Chicago.